KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pfizer (PFE) Other Accumulated Expenses (2016 - 2025)

Pfizer (PFE) has disclosed Other Accumulated Expenses for 15 consecutive years, with $18.6 billion as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 5.44% to $18.6 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $18.6 billion, a 5.44% decrease, with the full-year FY2025 number at $18.6 billion, down 5.44% from a year prior.
  • Other Accumulated Expenses was $18.6 billion for Q4 2025 at Pfizer, down from $19.5 billion in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $24.9 billion in Q4 2021 to a low of $12.8 billion in Q2 2021.
  • A 5-year average of $19.6 billion and a median of $19.7 billion in 2022 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: soared 115.72% in 2021, then crashed 32.49% in 2023.
  • Pfizer's Other Accumulated Expenses stood at $24.9 billion in 2021, then dropped by 9.51% to $22.6 billion in 2022, then fell by 9.0% to $20.5 billion in 2023, then decreased by 3.98% to $19.7 billion in 2024, then dropped by 5.44% to $18.6 billion in 2025.
  • Per Business Quant, the three most recent readings for PFE's Other Accumulated Expenses are $18.6 billion (Q4 2025), $19.5 billion (Q3 2025), and $18.6 billion (Q2 2025).